CD27 and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, CD70 was induced in LSCs by upregulating transcription factor specificity protein 1 in tyrosine kinase inhibitor-treated CML patients, triggering CD27 signaling which compensated Wnt pathway and therefore ultimately causing relapse [94].